{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:18Z","timestamp":1786982598767,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13277-015-3689-3","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T06:44:49Z","timestamp":1435560289000},"page":"9437-9446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines"],"prefix":"10.1007","volume":"36","author":[{"given":"Canan","family":"Ero\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fccahit","family":"Se\u00e7me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclseren","family":"Ba\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Dodurga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"3689_CR1","author":"E Szliszka","year":"2011","unstructured":"Szliszka E, Krol W. Polyphenols isolated from propolis augment TRAIL-induced apoptosis in cancer cells. Evid Based Complement Alternat Med. 2011. doi: 10.1155\/2013\/731940 .","journal-title":"Evid Based Complement Alternat Med"},{"key":"3689_CR2","author":"S Cimino","year":"2012","unstructured":"Cimino S, Sortino G, Favilla V, Castelli T, Madonia M, Sansalone S, et al. Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev. 2012. doi: 10.1155\/2012\/632959 .","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"3689_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3816\/CGC.2004.n.026","volume":"3","author":"JL Chin","year":"2004","unstructured":"Chin JL, Reiter RE. Molecular markers and prostate cancer prognosis. Clin Prostate Cancer. 2004;3(3):157\u201364.","journal-title":"Clin Prostate Cancer"},{"issue":"4","key":"3689_CR4","first-page":"213","volume":"8","author":"V Velcheti","year":"2008","unstructured":"Velcheti V, Karnik S, Bardot SF, Prakash O. Pathogenesis of prostate cancer: lessons from basic research. Ochsner J. 2008;8(4):213\u20138.","journal-title":"Ochsner J"},{"issue":"13","key":"3689_CR5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schroder","year":"2009","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"3689_CR6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/med.20060","volume":"26","author":"P Fresco","year":"2009","unstructured":"Fresco P, Borges F, Diniz C, Marques MP. New insights on the anticancer properties of dietary polyphenols. Med Res Rev. 2009;26(6):747\u201366.","journal-title":"Med Res Rev"},{"issue":"1","key":"3689_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/138161210789941856","volume":"16","author":"P Fresco","year":"2010","unstructured":"Fresco P, Borges F, Marques MP, Diniz C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des. 2010;16(1):114\u201334.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3689_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01635580903191585","volume":"62","author":"WY Huang","year":"2010","unstructured":"Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010;62(1):1\u201320.","journal-title":"Nutr Cancer"},{"issue":"4","key":"3689_CR9","first-page":"348","volume":"43","author":"M D\u2019Archivio","year":"2007","unstructured":"D\u2019Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 2007;43(4):348\u201361.","journal-title":"Ann Ist Super Sanita"},{"key":"3689_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D","volume":"79","author":"MN Clifford","year":"1999","unstructured":"Clifford MN. Chlorogenic acids and other cinnamates\u2014nature, occurrence and dietary burden. J Sci Food Agric. 1999;79:362\u201372.","journal-title":"J Sci Food Agric"},{"key":"3689_CR11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2013.10.003","volume":"52","author":"C Carbone","year":"2014","unstructured":"Carbone C, Campisi A, Musumeci T, Raciti G, Bonfanti R, Puglisi G. FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur J Pharm Sci. 2014;52:12\u201320.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3689_CR12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/01635581.2011.538486","volume":"63","author":"B Janicke","year":"2011","unstructured":"Janicke B, Hegardt C, Krogh M, Onning G, Akesson B, Cirenajwis HM, et al. The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells. Nutr Cancer. 2011;63(4):611\u201322.","journal-title":"Nutr Cancer"},{"issue":"32","key":"3689_CR13","doi-asserted-by":"crossref","first-page":"20213","DOI":"10.1074\/jbc.273.32.20213","volume":"273","author":"KE Knudsen","year":"1998","unstructured":"Knudsen KE, Arden KC, Cavenee WK. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J Biol Chem. 1998;273(32):20213\u201322.","journal-title":"J Biol Chem"},{"key":"3689_CR14","doi-asserted-by":"crossref","unstructured":"Balk SP and Knudsen KE. AR, the cell cycle, and prostate cancer. Nucl Recept Signal. 2008; doi: 10.1621\/nrs.06001","DOI":"10.1621\/nrs.06001"},{"issue":"15","key":"3689_CR15","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1158\/0008-5472.CAN-05-4472","volume":"66","author":"Y Xu","year":"2006","unstructured":"Xu Y, Chen SY, Ross KN, Balk SP. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and posttranscriptional increases in cyclin D proteins. Cancer Res. 2006;66(15):7783\u201392.","journal-title":"Cancer Res"},{"issue":"1","key":"3689_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.2990260108","volume":"26","author":"JD Brooks","year":"1995","unstructured":"Brooks JD, Bova GS, Isaacs WB. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate. 1995;26(1):35\u20139.","journal-title":"Prostate"},{"issue":"1","key":"3689_CR17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(96)90134-3","volume":"27","author":"MM Ittmann","year":"1996","unstructured":"Ittmann MM, Wieczorek R. Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas. Hum Pathol. 1996;27(1):28\u201334.","journal-title":"Hum Pathol"},{"issue":"2","key":"3689_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<108::AID-GCC5>3.0.CO;2-7","volume":"15","author":"JV Tricoli","year":"1996","unstructured":"Tricoli JV, Gumerlock PH, Yao JL, Chi SG, D\u2019Souza SA, Nestok BR, et al. Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer. 1996;15(2):108\u201314.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"3689_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3835(02)00282-3","volume":"185","author":"DF Jarrard","year":"2002","unstructured":"Jarrard DF, Modder J, Fadden P, Fu V, Sebree L, Heisey D, et al. Alterations in the p16\/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Lett. 2002;185(2):191\u20139.","journal-title":"Cancer Lett"},{"key":"3689_CR20","author":"CC Peng","year":"2013","unstructured":"Peng CC, Chyau CC, Wang HE, Chang CH, Chen KC, Chou KY, et al. Cytotoxicity of Ferulic acid on T24 cell line differentiated by different microenvironments. BioMed Res Int. 2013. doi: 10.1155\/2013\/579859 .","journal-title":"BioMed Res Int"},{"issue":"2","key":"3689_CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phymed.2012.10.009","volume":"20","author":"S Hemaiswarya","year":"2013","unstructured":"Hemaiswarya S, Doble M. Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line. Phytomedicine. 2013;20(2):151\u20138.","journal-title":"Phytomedicine"},{"issue":"2","key":"3689_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1207\/s15327914nc5202_11","volume":"52","author":"SD Cho","year":"2005","unstructured":"Cho SD, Li G, Hu H, Jiang C, Kang KS, Lee YS, et al. Involvement of c-Jun N-terminal kinase in G2\/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer. 2005;52(2):213\u201324.","journal-title":"Nutr Cancer"},{"key":"3689_CR23","author":"S Karanika","year":"2014","unstructured":"Karanika S, Karantanos T, Li L, Corn PG, Thompson TC. DNA damage response and prostate cancer: defects, regulation and therapeutic implications. Oncogene. 2014. doi: 10.1038\/onc.2014.238 .","journal-title":"Oncogene"},{"issue":"6","key":"3689_CR24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jcb.20281","volume":"93","author":"Y Hou","year":"2004","unstructured":"Hou Y, Yang J, Zhao G, Yuan Y. Ferulic acid inhibits endothelial cell proliferation through NO downregulating ERK1\/2 pathway. J Cell Biochem. 2004;93(6):1203\u20139.","journal-title":"J Cell Biochem"},{"issue":"4","key":"3689_CR25","doi-asserted-by":"crossref","first-page":"e10147","DOI":"10.1371\/journal.pone.0010147","volume":"5","author":"Q Dong","year":"2010","unstructured":"Dong Q, Meng P, Wang T, Qin W, Wang F, Yuan J, et al. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One. 2010;5(4):e10147.","journal-title":"PLoS One"},{"issue":"13","key":"3689_CR26","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1128\/MCB.00862-06","volume":"27","author":"E Susaki","year":"2007","unstructured":"Susaki E, Nakayama K, Nakayama KI. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Mol Cell Biol. 2007;27(13):4626\u201340.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3689_CR27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s11255-008-9350-y","volume":"40","author":"D Nikoleishvili","year":"2008","unstructured":"Nikoleishvili D, Pertia A, Trsintsadze O, Gogokhia N, Managadze L, Chkhotua A. Expression of p27(Kip1), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells. Int Urol Nephrol. 2008;40(4):953\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"7302","key":"3689_CR28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature09140","volume":"466","author":"V D\u2019Angiolella","year":"2010","unstructured":"D\u2019Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, et al. SCF(cyclin F) controls centrosome homeostasis and mitotic fidelity via CP110 degradation. Nature. 2010;466(7302):138\u201342.","journal-title":"Nature"},{"issue":"3","key":"3689_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1350-9462(99)00018-X","volume":"19","author":"JD Zieske","year":"2000","unstructured":"Zieske JD. Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog Retin Eye Res. 2000;19(3):257\u201370.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3689_CR30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ol.2013.1563","volume":"6","author":"H Sirma","year":"2013","unstructured":"Sirma H, Broemel M, Stumm L, Tsourlakis T, Steurer S, Tennstedt P, et al. Loss of CDKN1B\/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6(5):1245\u201352.","journal-title":"Oncol Lett"},{"issue":"6","key":"3689_CR31","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0092-8674(91)90557-F","volume":"65","author":"SP Chellappan","year":"1991","unstructured":"Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the Rb protein. Cell. 1991;65(6):1053\u201362.","journal-title":"Cell"},{"issue":"10","key":"3689_CR32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4161\/cc.6.10.4259","volume":"6","author":"D Plesca","year":"2007","unstructured":"Plesca D, Crosby ME, Gupta D, Almasan A. E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA. Cell Cycle. 2007;6(10):1147\u201352.","journal-title":"Cell Cycle"},{"issue":"3","key":"3689_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S. Apoptosis by death factor. Cell. 1997;88(3):355\u201365.","journal-title":"Cell"},{"issue":"1","key":"3689_CR34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/onc.2009.40","volume":"27","author":"G Chinnadurai","year":"2008","unstructured":"Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene. 2008;27(1):20\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"3689_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13277-012-0545-6","volume":"34","author":"VR Bandagula","year":"2013","unstructured":"Bandagula VR, Prasad NR. 2-Deoxy-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells. Tumour Biol. 2013;34(1):251\u20139.","journal-title":"Tumour Biol"},{"issue":"6","key":"3689_CR36","first-page":"1366","volume":"59","author":"Y Guo","year":"1999","unstructured":"Guo Y, Kyprianou N. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res. 1999;59(6):1366\u201371.","journal-title":"Cancer Res"},{"issue":"3","key":"3689_CR37","first-page":"1227","volume":"61","author":"RN Winter","year":"2001","unstructured":"Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 2001;61(3):1227\u201332.","journal-title":"Cancer Res"},{"issue":"3","key":"3689_CR38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10495-006-0009-9","volume":"12","author":"RL VanOosten","year":"2007","unstructured":"VanOosten RL, Earel Jr JK, Griffith TS. Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity. Apoptosis. 2007;12(3):561\u201371.","journal-title":"Apoptosis"},{"issue":"2","key":"3689_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/bcr752","volume":"6","author":"M Kampa","year":"2004","unstructured":"Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res. 2004;6(2):63\u201374.","journal-title":"Breast Cancer Res"},{"issue":"13","key":"3689_CR40","first-page":"4914","volume":"9","author":"M Krajewska","year":"2003","unstructured":"Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res. 2003;9(13):4914\u201325.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3689_CR41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.humpath.2004.03.011","volume":"35","author":"U Ramp","year":"2004","unstructured":"Ramp U, Krieg T, Caliskan E, Mahotka C, Ebert T, Willers R, et al. XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum Pathol. 2004;35(8):1022\u20138.","journal-title":"Hum Pathol"},{"issue":"7","key":"3689_CR42","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.tiv.2011.05.007","volume":"25","author":"S Karthikeyan","year":"2011","unstructured":"Karthikeyan S, Kanimozhi G, Prasad NR, Mahalakshmi R. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol In Vitro. 2011;25(7):1366\u201375.","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"3689_CR43","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1021\/mp3006648","volume":"10","author":"CM Tsai","year":"2013","unstructured":"Tsai CM, Yen GC, Sun FM, Yang SF, Weng CJ. Assessment of the anti-invasion potential and mechanism of select cinnamic acid derivatives on human lung adenocarcinoma cells. Mol Pharm. 2013;10(5):1890\u2013900.","journal-title":"Mol Pharm"},{"key":"3689_CR44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.fct.2013.05.019","volume":"58","author":"HY Fang","year":"2013","unstructured":"Fang HY, Wang HM, Chang KF, Hu HT, Hwang LJ, Fu TF, et al. Feruloyl-L-arabinose attenuates migration, invasion and production of reactive oxygen species in H1299 lung cancer cells. Food ChemToxicol. 2013;58:459\u201366. doi: 10.1016\/j.fct.2013.05.019 .","journal-title":"Food ChemToxicol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3689-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3689-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3689-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:04:55Z","timestamp":1566921895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3689-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3689"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3689-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}